Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOVER HEALTH INVESTMENTS, CORP. /DECLOV · Entity 4419 | Director | September 30, 2026 | October 03, 2026 |
| GlassBridge Enterprises, Inc.GLAE · Entity 93391 | Director | September 22, 2023 | March 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOVER HEALTH INVESTMENTS, CORP. /DE
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 186,897 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 12,481 · Balance 186,897 F1: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.
GlassBridge Enterprises, Inc.
Report date September 22, 2023 · Filed March 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 935 |
Reported balance
After 2023-09-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-09-22 · Grant · Acquired 935 · Balance 935 F1: The restricted stock unit ("RSUs") may be settled solely in cash. The Awardee of each cash-settled RSU shall be entitled to receive an amount equal to the product of the excess of (i) the fair market value of one share of common stock of GlassBridge Enterprises, Inc. (the "Company") as of the business day immediately preceding the date on which the cash-out notice is delivered to the Company minus (ii) $164.95. F2: The RSUs shall vest in proportion to (i) the aggregate number of Series 1 RSUs and Series 2 RSUs (as each such term is defined in the Stock Purchase Agreement dated as of September 25, 2023 by and between the Company and Tacora Capital, L.P. ("Tacora")) purchased by Tacora, divided by (ii) 75,000 (in all events without duplication), but in any event in equal quarterly installments over a 4-year period beginning on September 25, 2023. |
| Non-Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.00 | Direct | 331 |
Reported balance
After 2023-09-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-09-22 · Grant · Acquired 331 · Balance 331 F3: The shares underlying the Option shall vest over a four-year period in equal quarterly installments beginning on September 22, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit ("RSUs") may be settled solely in cash. The Awardee of each cash-settled RSU shall be entitled to receive an amount equal to the product of the excess of (i) the fair market value of one share of common stock of GlassBridge Enterprises, Inc. (the "Company") as of the business day immediately preceding the date on which the cash-out notice is delivered to the Company minus (ii) $164.95.
F2: The RSUs shall vest in proportion to (i) the aggregate number of Series 1 RSUs and Series 2 RSUs (as each such term is defined in the Stock Purchase Agreement dated as of September 25, 2023 by and between the Company and Tacora Capital, L.P. ("Tacora")) purchased by Tacora, divided by (ii) 75,000 (in all events without duplication), but in any event in equal quarterly installments over a 4-year period beginning on September 25, 2023.
F3: The shares underlying the Option shall vest over a four-year period in equal quarterly installments beginning on September 22, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:14 UTC | CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV · Entity 4419 | GrantClass A Common Stock | 12,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-26-000243 · wk-form4_1790972057.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,897 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| September 22, 2023 Filed Mar 7, 2024 21:58 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantNon-Qualified Stock Option · Derivative | 331 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001493152-24-009234 · ownership.xml · derivative · entry 2 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331 Underlying: Common Stock · 331 shares Expires not disclosed F3 · derivative.exercise_date: The shares underlying the Option shall vest over a four-year period in equal quarterly installments beginning on September 22, 2023. F3 · derivative.expiration_date: The shares underlying the Option shall vest over a four-year period in equal quarterly installments beginning on September 22, 2023. Read SEC document |
| September 22, 2023 Filed Mar 7, 2024 21:58 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantRestricted Stock Unit · Derivative | 935 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-009234 · ownership.xml · derivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 935 Underlying: Common Stock · 935 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock unit ("RSUs") may be settled solely in cash. The Awardee of each cash-settled RSU shall be entitled to receive an amount equal to the product of the excess of (i) the fair market value of one share of common stock of GlassBridge Enterprises, Inc. (the "Company") as of the business day immediately preceding the date on which the cash-out notice is delivered to the Company minus (ii) $164.95. F2 · derivative.exercise_date: The RSUs shall vest in proportion to (i) the aggregate number of Series 1 RSUs and Series 2 RSUs (as each such term is defined in the Stock Purchase Agreement dated as of September 25, 2023 by and between the Company and Tacora Capital, L.P. ("Tacora")) purchased by Tacora, divided by (ii) 75,000 (in all events without duplication), but in any event in equal quarterly installments over a 4-year period beginning on September 25, 2023. F2 · derivative.expiration_date: The RSUs shall vest in proportion to (i) the aggregate number of Series 1 RSUs and Series 2 RSUs (as each such term is defined in the Stock Purchase Agreement dated as of September 25, 2023 by and between the Company and Tacora Capital, L.P. ("Tacora")) purchased by Tacora, divided by (ii) 75,000 (in all events without duplication), but in any event in equal quarterly installments over a 4-year period beginning on September 25, 2023. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 13:02 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | OtherCommon Stock | 250 | $50.01 | $12,502.50 |
DisclosureSEC source: 0001493152-21-000151 · ownership.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80 F1 · kind: Transferred to third party pursuant to settlement agreement. F1 · price: Transferred to third party pursuant to settlement agreement. Read SEC document |
| September 06, 2019 Filed May 7, 2020 17:22 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantStock Option (Right to Buy) · Derivative | 145 | $0.00 Strike: $106.00 | $0.00 |
DisclosureSEC source: 0001493152-20-007902 · ownership.xml · derivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145 Underlying: Common Stock · 145 shares Expires 2029-09-06 F1 · derivative.exercise_date: The stock option vests in twelve equal installments (with respect to approximately 12.083 shares of common stock) on the first day of each calendar quarter commencing: January 1, 2020. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:29 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantCommon Stock | 13,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-032059 · tv495600_form4.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,095 F1 · security: These shares were granted as a restricted stock award and will vest on August 28, 2018, subject to the recipient's continuous service as a member of the Issuer's board of directors on the vesting date. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:12 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantCommon Stock | 9,398 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-012312 · tv487475_form4.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,937 F1 · security: These shares were granted as a restricted stock award and will vest on August 28, 2018, subject to the recipient's continuous service as a member of the Issuer's board of directors on the vesting date. Read SEC document |
| November 28, 2017 Filed Nov 30, 2017 21:05 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantCommon Stock | 9,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-061700 · tv480472_form4.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,539 F1 · security: These shares were granted as a restricted stock award and will vest on August 28, 2018, subject to the recipient's continuous service as a member of the Issuer's board of directors on the vesting date. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 22:13 UTC | GlassBridge Enterprises, Inc. GLAE · Entity 93391 | GrantCommon Stock | 5,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-046006 · v474409_form4.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,280 F1 · security: These shares were granted as a restricted stock award and will vest on August 28, 2018, subject to the recipient's continuous service as a member of the Issuer's board of directors on the vesting date. Read SEC document |
| May 17, 2017 Filed May 19, 2017 21:17 UTC | GlassBridge Enterprises, Inc. GLA · Entity 93391 | OtherCommon Stock | 28,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-028690 · v467521_4.xml · nonDerivative · entry 1 Torricelli Robert G · CIK 0001700139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,724 F1 · kind: The reported transaction represents securities received by the Reporting Person as a limited partner in a limited partnership pursuant to an in kind pro rata distribution. In prior reports, these securities were reported as indirectly beneficially owned by Clinton Group Inc. and George E. Hall. F1 · price: The reported transaction represents securities received by the Reporting Person as a limited partner in a limited partnership pursuant to an in kind pro rata distribution. In prior reports, these securities were reported as indirectly beneficially owned by Clinton Group Inc. and George E. Hall. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.